Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 765 across all filing types
Latest filing 2025-01-20 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
POSSIBLE MAJOR TRANSACTION AND DEEMED DISPOSAL IN RELATION TO PROPOSED LISTING OF SICHUAN RUIJIAN MEDICAL ON BEIJING STOCK EXCHANGE AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an extensive circular addressed to shareholders of PW Medtech Group Limited, including a “Letter from the Board,” detailed transaction information regarding a possible major transaction and deemed disposal, financial appendices, a notice convening an Extraordinary General Meeting (EGM), and a proxy form. It is clearly a solicitation of voting instructions for shareholders in respect of the EGM approval. This matches the definition of a Proxy Solicitation & Information Statement (Code: PSI).
2025-01-20 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 1% confidence The document is a short announcement stating a postponement of the dispatch date for a shareholder circular (the “Circular”). It does not contain the substantive circular content itself but only informs investors of the delay in publication/dispatch. Under the “menu vs meal” rule, such notices are classified as Report Publication Announcements (RPA).
2025-01-13 English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement notifying a change in the company’s principal place of business address. It is not a financial report, dividend notice, proxy, or management change but a general regulatory announcement. There is no specific category for an office address change, so it falls under the generic “Regulatory Filings” category (RNS).
2025-01-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings Classification · 1% confidence The document is the Hong Kong Exchange’s monthly FF301 return covering movements in issued, treasury, and authorised share capital for the month ended 31 December 2024. It is a periodic regulatory filing under the Exchange Listing Rules rather than a standalone annual report, earnings release, proxy statement, or director share dealing notice. There is no specific category for monthly Listing Rule returns, so it falls into the general Regulatory Filings fallback.
2025-01-07 English
DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 1% confidence The document is a brief Stock Exchange announcement titled “Delay in Despatch of Circular” notifying shareholders of a postponed mailing date for the circular (EGM materials). It does not contain the actual circular content but simply announces the timing of its dispatch. This fits the definition of a Report Publication Announcement (RPA).
2024-12-31 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under the Hong Kong Stock Exchange Listing Rules detailing changes in issued shares and treasury shares, specifically share repurchases and on-market sales of treasury shares. It provides a detailed repurchase report and confirms compliance with listing rules. This matches the “Transaction in Own Shares” category, which covers company buybacks and sales of its own shares (Code: POS).
2024-12-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.